ResMed Inc. ResMed Inc.

ResMed Inc.

RMD

株式のランク #707
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
株価
$244.92
時価総額
$34.45B
変化(1日)
2.20%
変化(1年)
-9.76%
国
US
取引 ResMed Inc. (RMD)

カテゴリー

Healthcare
ResMed Inc.(RMD)の利益
Jun 2026 時点の利益 TTM: $1.92B
ResMed Inc. の最新の財務報告によると、同社の現在の利益は $1.92B です。2024 年には $1.26B の利益を上げ、これは 2023 年の利益 $1.10B と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
ResMed Inc. の利益の推移(2000 〜 2026)
各年末の利益
年 利益 変化
2026 (TTM) $1.92B 14.42%
2025 $1.68B 32.64%
2024 $1.26B 14.81%
2023 $1.10B 14.70%
2022 $960.48M 8.69%
2021 $883.66M 20.54%
2020 $733.09M 41.29%
2019 $518.85M -0.47%
2018 $521.31M 24.49%
2017 $418.74M -4.74%
2016 $439.57M 0.84%
2015 $435.92M 1.12%
2014 $431.08M 11.93%
2013 $385.12M 16.02%
2012 $331.95M 9.30%
2011 $303.71M 16.55%
2010 $260.59M 29.21%
2009 $201.68M 27.77%
2008 $157.86M 61.12%
2007 $97.97M -26.55%
2006 $133.39M 38.05%
2005 $96.63M 14.12%
2004 $84.67M 26.13%
2003 $67.13M 22.96%
2002 $54.59M 99.87%
2001 $27.31M -20.06%
2000 $34.17M 0.00%
同業他社の利益
企業 利益 利益の差 国
$7.51B 291.32%
US
$5.56B 189.83%
IE
$5.15B 168.21%
US
$3.86B 101.15%
US
- -
DE